$HSTO Histogen Inc. Insider Trading Week 30/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Histogen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Histogen Inc. in week 30/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | A | 0.00 | 86,375 | 0 | 86,375 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 2.00 | 50,000 | 100,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 5.17 | 16,000 | 82,720 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 4.21 | 23,000 | 96,830 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 2.09 | 20,000 | 41,800 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 1.85 | 3,750 | 6,938 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 1.85 | 15,000 | 27,750 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 6.40 | 15,000 | 96,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 9.45 | 15,000 | 141,750 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | VANDERTIE MICHELLE L | Vice President, Fin ... | Option Exercise | D | 9.61 | 15,000 | 144,150 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | A | 0.00 | 313,436 | 0 | 313,436 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 2.00 | 175,000 | 350,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 5.17 | 70,000 | 361,900 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 4.21 | 100,625 | 423,631 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 1.85 | 21,875 | 40,469 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 1.85 | 109,375 | 202,344 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 6.40 | 100,000 | 640,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | EVP, R&D and CSO | Option Exercise | D | 9.45 | 50,000 | 472,500 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | A | 0.00 | 385,000 | 0 | 385,000 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | D | 2.00 | 175,000 | 350,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | D | 5.17 | 70,000 | 361,900 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Marshall Keith W | EVP, COO & CFO | Option Exercise | D | 5.74 | 525,000 | 3,013,500 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 0.00 | 650,000 | 0 | 650,000 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 2.00 | 350,000 | 700,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 5.17 | 120,000 | 620,400 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 4.21 | 172,500 | 726,225 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 1.85 | 37,500 | 69,375 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 1.85 | 20,000 | 37,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 6.40 | 50,000 | 320,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 6.40 | 150,000 | 960,000 | 0 | |
| Aug 01 2019 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | D | 9.45 | 400,000 | 3,780,000 | 0 |